CHAMPIONS ONCOLOGY, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$5.85 million for the 9-month period ending 2016-01-31, per its 10-Q filed 2016-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2016-03-16
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-01-31 was -$726.00K.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-10-31 was -$2.58M.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-07-31 was -$2.54M.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-04-30 was -$2.01M, a 1706.40% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$9.63M.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$3.43M.
- CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$4.30M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-01-31 | -$726.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$3.31M derived: sum of 2 quarters · filed 2016-03-16 | -$5.85M 10-Q · filed 2016-03-16 | -$7.86M derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-10-31 | -$2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$5.13M 10-Q · filed 2015-12-15 | -$7.13M derived: sum of 3 quarters · filed 2015-12-15 | -$9.51M derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-07-31 | -$2.54M 10-Q · filed 2015-09-11 | -$4.55M derived: sum of 2 quarters · filed 2015-09-11 | -$6.93M derived: sum of 3 quarters · filed 2016-03-16 | -$9.38M derived: sum of 4 quarters · filed 2016-03-16 |
| 2015-04-30 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$4.38M derived: sum of 2 quarters · filed 2016-03-16 | -$6.84M derived: sum of 3 quarters · filed 2016-03-16 | -$9.63M 10-K · filed 2015-07-29 |
| 2015-01-31 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$4.83M derived: sum of 2 quarters · filed 2016-03-16 | -$7.62M 10-Q · filed 2016-03-16 | -$7.50M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | -$2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$5.25M 10-Q · filed 2015-12-15 | -$5.12M derived: sum of 3 quarters · filed 2015-12-15 | -$6.78M derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | -$2.79M 10-Q · filed 2015-09-11 | -$2.66M derived: sum of 2 quarters · filed 2015-09-11 | -$4.32M derived: sum of 3 quarters · filed 2015-09-11 | -$4.08M derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$1.53M derived: sum of 2 quarters · filed 2015-07-29 | -$1.29M derived: sum of 3 quarters · filed 2015-07-29 | -$3.43M 10-K · filed 2015-07-29 |
| 2014-01-31 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$1.41M derived: sum of 2 quarters · filed 2015-03-17 | -$3.56M 10-Q · filed 2015-03-17 | -$4.73M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$1.90M 10-Q · filed 2014-12-15 | -$3.07M derived: sum of 3 quarters · filed 2014-12-15 | |
| 2013-07-31 | -$2.14M 10-Q · filed 2014-09-12 | -$3.31M derived: sum of 2 quarters · filed 2014-09-12 | ||
| 2013-04-30 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | -$4.30M 10-K · filed 2014-07-28 | ||
| 2013-01-31 | -$3.13M 10-Q · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |